Your browser doesn't support javascript.
loading
Photoaffinity Labeling of Pentameric Ligand-Gated Ion Channels: A Proteomic Approach to Identify Allosteric Modulator Binding Sites.
Jayakar, Selwyn S; Ang, Gordon; Chiara, David C; Hamouda, Ayman K.
Afiliação
  • Jayakar SS; Department of Neurobiology, Harvard Medical School, Boston, MA, USA.
  • Ang G; Department of Pharmaceutical Sciences, College of Pharmacy, Texas A&M Health Sciences Center, Kingsville, TX, USA.
  • Chiara DC; Department of Neurobiology, Harvard Medical School, Boston, MA, USA.
  • Hamouda AK; Department of Pharmaceutical Sciences, College of Pharmacy, Texas A&M Health Sciences Center, Kingsville, TX, USA. Hamouda@tamhsc.edu.
Methods Mol Biol ; 1598: 157-197, 2017.
Article em En | MEDLINE | ID: mdl-28508361
ABSTRACT
Photoaffinity labeling techniques have been used for decades to identify drug binding sites and to study the structural biology of allosteric transitions in transmembrane proteins including pentameric ligand-gated ion channels (pLGIC). In a typical photoaffinity labeling experiment, to identify drug binding sites, UV light is used to introduce a covalent bond between a photoreactive ligand (which upon irradiation at the appropriate wavelength converts to a reactive intermediate) and amino acid residues that lie within its binding site. Then protein chemistry and peptide microsequencing techniques are used to identify these amino acids within the protein primary sequence. These amino acid residues are located within homology models of the receptor to identify the binding site of the photoreactive probe. Molecular modeling techniques are then used to model the binding of the photoreactive probe within the binding site using docking protocols. Photoaffinity labeling directly identifies amino acids that contribute to drug binding sites regardless of their location within the protein structure and distinguishes them from amino acids that are only involved in the transduction of the conformational changes mediated by the drug, but may not be part of its binding site (such as those identified by mutational studies). Major limitations of photoaffinity labeling include the availability of photoreactive ligands that faithfully mimic the properties of the parent molecule and protein preparations that supply large enough quantities suitable for photoaffinity labeling experiments. When the ligand of interest is not intrinsically photoreactive, chemical modifications to add a photoreactive group to the parent drug, and pharmacological evaluation of these chemical modifications become necessary. With few exceptions, expression and affinity-purification of proteins are required prior to photolabeling. Methods to isolate milligram quantities of highly enriched pLGIC suitable for photoaffinity labeling experiments have been developed. In this chapter, we discuss practical aspects of experimental strategies to identify allosteric modulator binding sites in pLGIC using photoaffinity labeling.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marcadores de Fotoafinidade / Proteômica / Descoberta de Drogas / Canais Iônicos de Abertura Ativada por Ligante / Ligantes Tipo de estudo: Guideline Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marcadores de Fotoafinidade / Proteômica / Descoberta de Drogas / Canais Iônicos de Abertura Ativada por Ligante / Ligantes Tipo de estudo: Guideline Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article